How many drugs treat von Willebrand disorder?

Drug Landscape tracks 4 marketed treatments for von Willebrand disorder (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/von-willebrand-disorder.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

von Willebrand disorder — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

von Willebrand disorder (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating von Willebrand disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vonvendi	VONICOG ALFA	Baxalta US Inc.			2015-01-01
Ddavp	DESMOPRESSIN	Ferring Pharms Inc	Factor VIII Activator	Vasopressin V1b receptor	1978-01-01
Minirin	Minirin	Hormozgan University of Medical Sciences		Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor
Argipressin	Argipressin	Kristina Svennerholm		Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxalta US Inc. · 1 drug in von Willebrand disorder
Ferring Pharms Inc · 1 drug in von Willebrand disorder
Hormozgan University of Medical Sciences · 1 drug in von Willebrand disorder
Kristina Svennerholm · 1 drug in von Willebrand disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in von Willebrand disorder:

Cite this brief

Drug Landscape (2026). von Willebrand disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/von-willebrand-disorder. Accessed 2026-06-11.

von Willebrand disorder full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing